FDA Adverse Event Injury Summary report: N

ISPAN PERFLUOROPROPANE (C3F8) GAS

MDR report key: 21426185 · Received February 20, 2025

Report

Report Number
0002518435-2025-00012
Event Type
Injury
Date Received
February 20, 2025
Date of Event
November 23, 2024
Report Date
January 28, 2024
Manufacturer
AIRGAS THERAPEUTICS LLC
Product Code
LPO
PMA / PMN Number
P900066
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO SAMPLE WAS RETURNED FOR EVALUATION. AN ANALYSIS OF THE RETAIN SAMPLE FROM THE SAME LOT OF PERFLUOROPROPANE SHOWED THAT THE PRODUCT WAS PFP AND MET ALL RELEASE CRITERIA. NOTHING WAS FOUND THAT WOULD ACCOUNT FOR THE REPORTED EVENT.

Additional Manufacturer Narrative · 0

NO SAMPLE WAS RETURNED FOR EVALUATION. AN ANALYSIS OF THE RETAIN SAMPLE FROM THE SAME LOT OF PERFLUOROPROPANE SHOWED THAT THE PRODUCT WAS PFP AND MET ALL RELEASE CRITERIA. NOTHING WAS FOUND THAT WOULD ACCOUNT FOR THE REPORTED EVENT. THIS IS A DUPLICATE OF MDR# 0002518435-2025-00007.

Description of Event or Problem · 0

A HEALTHCARE PROFESSIONAL VIA STUDY REPORTED THAT AFTER VITRECTOMY SURGERY, THE PATIENT EXPERIENCED MILD SECONDARY GLAUCOMA IN THE LEFT EYE. THE PATIENT WAS GIVEN DRUG TREATMENT AND THE EVENT WAS RESOLVED.

Description of Event or Problem · 0

A HEALTHCARE PROFESSIONAL VIA STUDY REPORTED THAT AFTER VITRECTOMY SURGERY, THE PATIENT EXPERIENCED MILD SECONDARY GLAUCOMA IN THE LEFT EYE. THE PATIENT WAS GIVEN DRUG TREATMENT AND THE EVENT WAS RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
394696 ISPAN PERFLUOROPROPANE (C3F8) GAS INTRAOCULAR GAS LPO AIRGAS THERAPEUTICS LLC 300502

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other| R